290650 — L&C Bio Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Market Cap
KR₩512bn
Enterprise Value
KR₩622bn
Revenue
KR₩72bn

Annual balance sheet for L&C Bio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	27,344	19,620	12,316	59,193	24,137
Net Total Accounts Receivable
Net Total Receivables	9,306	13,242	13,553	19,894	52,049
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	45,501	47,632	64,284	130,357	130,189
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9,483	17,895	53,138	74,655	97,017
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	80,576	107,401	199,725	262,230	475,601
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3,675	5,635	18,738	101,838	154,708
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	22,769	22,380	101,773	115,285	191,248
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	57,806	85,021	97,952	146,945	284,353
Total Liabilities & Shareholders' Equity	80,576	107,401	199,725	262,230	475,601
Total Common Shares Outstanding